Andrada Mining acquisition elevates the miner to emerging mid-tier status. Watch the video here.

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksCoca-Cola HBC Regulatory News (CCH)

Share Price Information for Coca-Cola HBC (CCH)

London Stock Exchange
Share Price is delayed by 15 minutes
Get Live Data
Share Price: 2,716.00
Bid: 2,714.00
Ask: 2,718.00
Change: -26.00 (-0.95%)
Spread: 4.00 (0.147%)
Open: 2,746.00
High: 2,754.00
Low: 2,714.00
Prev. Close: 2,742.00
CCH Live PriceLast checked at -

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

Result of AGM

26 Jun 2014 09:45

RNS Number : 6151K
Coca-Cola HBC AG
26 June 2014
 



FOR IMMEDIATE RELEASE

 

Coca-Cola HBC AG

Results of Annual General Meeting of Coca-Cola HBC AG and election of Anastasios I. Leventis, Christo Leventis, José Octavio Reyes and John P. Sechi as Non-Executive Directors

 

 

Zug, Switzerland - 26 June 2014 -Coca-Cola HBC AG ("Coca-Cola HBC") today announces that all of the proposals of the Board of Directors (the "Board") set out in the notice of the annual general meeting ("AGM") dated 28 May 2013 were duly passed by the requisite majority of shareholders at its AGM held on Wednesday 25 June 2014. The final results are set out below. A copy of the resolutions passed at the AGM has also been submitted to the National Storage Mechanism and will be available for inspection at http://www.morningstar.co.uk/uk/NSM and on Coca-Cola HBC's website at www.coca‑colahellenic.com

 

Following the retirement of Anastasios P. Leventis, Haralambos K. Leventis, John Hunter and Stefan F. Heidenreich from the Board as of the AGM, Coca-Cola HBC's shareholders elected Anastasios I. Leventis, Christo Leventis, José Octavio Reyes and John P. Sechi as non-executive directors. Biographies of the new non-executive directors can be found at www.coca‑colahellenic.com.

 

In addition, the AGM approved amendments of the articles of association of Coca-Cola HBC in order to address the requirements of new Swiss legislation, the Swiss ordinance against excessive compensation in listed companies, which is aimed at curbing excessive executive compensation and strengthening shareholders' powers. The AGM also approved a dividend of EUR 0.354 per share to be paid out of capital contribution reserves. The full amount of EUR 0.354 per share will be paid on 29 July 2014 to holders of ordinary shares on the record date of 11 July 2014. The shares are expected to be traded ex-dividend as of 9 July 2014, in which case the last day on which the shares may be traded with the entitlement to receive dividends will be 8 July 2014.

Final ballot results

Proposal

Votes For

%(1)

Votes Against

%(1)

Abstentions cast

%(1)

Total votes cast

Votes not cast(2)

%(1)

Voting rights represented (%)(3)

1.

Receipt of the 2013 UK Annual Report and the 2012/2013 Report on Financial Statements and Other Information Required under Swiss Law, as well as approval of the annual management report, the stand-alone financial statements and the consolidated financial statements

240,740,505

99.76%

30,973

0.01%

563,257

0.23%

241,334,735

0

0%

100%

2.

 

Advisory vote on the Remuneration Report

207,182,638

85.85%

34,022,514

14.10%

129,583

0.05%

241,334,735

0

0%

100%

3.

Advisory vote on the Remuneration Policy

196,763,944

81.53%

39,583,175

16.40%

4,987,616

2.07%

241,334,735

0

0%

100%

4.

Appropriation of reserves / declaration of dividend

241,209,981

99.95%

283

0.00%

124,471

0.05%

241,334,735

0

0%

100%

5.

Discharge of the members of the Board of Directors and the members of the Operating Committee

241,087,664

99.90%

7,805

0.00%

239,266

0.10%

241,334,735

0

0%

100%

6.

Amendment of Articles of Association

202,068,626

83.73%

39,023,624

16.17%

242,485

0.10%

241,334,735

0

0%

100%

7.1.1.

Re-election of George A. David as a member of the Board of Directors and election as the Chairman of the Board of Directors (in a single vote)

237,566,663

98.44%

3,643,813

1.51%

124,259

0.05%

241,334,735

0

0%

100%

7.1.2.

Re-election of Antonio D'Amato as a member of the Board of Directors and election as a member of the Remuneration Committee (in a single vote)

240,111,456

99.50%

1,097,780

0.45%

125,499

0.05%

241,334,735

0

0%

100%

7.1.3.

Re-election of Sir Michael Llewellyn-Smith as a member of the Board of Directors and election as a member of the Remuneration Committee (in a single vote)

239,208,431

99.12%

2,000,810

0.83%

125,494

0.05%

241,334,735

0

0%

100%

7.1.4.

Re-election of Susan Kilsby as a member of the Board of Directors and election as a member of the Remuneration Committee (in a single vote)

 

241,175,684

99.94%

33,557

0.01%

125,494

0.05%

241,334,735

0

0%

100%

7.1.5.

Re-election of Dimitris Lois as a member of the Board of Directors

241,050,757

99.88%

158,796

0.07%

125,182

0.05%

241,334,735

0

0%

100%

7.1.6.

Re-election of Anastassis G. David as a member of the Board of Directors

238,709,787

98.91%

2,500,689

1.04%

124,259

0.05%

241,334,735

0

0%

100%

7.1.7.

Re-election of Irial Finan as a member of the Board of Directors

238,856,385

98.98%

2,352,571

0.97%

125,779

0.05%

241,334,735

0

0%

100%

7.1.8.

Re-election of Christos Ioannou as a member of the Board of Directors

241,177,424

99.94%

33,187

0.01%

124,124

0.05%

241,334,735

0

0%

100%

7.1.9.

Re-election of Nigel Macdonald as a member of the Board of Directors

240,570,602

99.69%

638,621

0.26%

125,512

0.05%

241,334,735

0

0%

100%

7.2.1.

Election of Anastasios I. Leventis as a member of the Board of Directors

239,326,767

99.17%

1,885,404

0.78%

122,564

0.05%

241,334,735

0

0%

100%

7.2.2.

Election of Christo Leventis as a member of the Board of Directors

239,326,507

99.17%

1,885,664

0.78%

122,564

0.05%

241,334,735

0

0%

100%

7.2.3.

Election of José Octavio Reyes as a member of the Board of Directors

239,322,344

99.17%

1,885,697

0.78%

126,694

0.05%

241,334,735

0

0%

100%

7.2.4.

Election of John P. Sechi as a member of the Board of Directors

240,581,929

99.69%

626,962

0.26%

125,844

0.05%

241,334,735

0

0%

100%

8.

Election of the independent proxy

241,210,280

99.95%

10

0.00%

124,445

0.05%

241,334,735

0

0%

100%

9.1.

Re-election of the statutory auditor

241,210,489

99.95%

20

0.00%

124,226

0.05%

241,334,735

0

0%

100%

9.2.

Advisory vote on re-appointment of the independent registered public accounting firm for UK and US purposes

241,178,854

99.94%

30,520

0.01%

125,361

0.05%

241,334,735

0

0%

100%

9.3.

Re-election of the audit expert for audits of capital increases

241,210,331

99.95%

43

0.00%

124,361

0.05%

241,334,735

0

0%

100%

(1) Percentages refer to applicable majority. Proposals 1-5 and 7.1.1-9.3 require approval by an absolute majority of the votes validly cast. Proposal 6 requires approval by a majority of two-thirds of the voting rights represented and an absolute majority of the nominal value of shares represented.

(2) Votes represented at the AGM but not (or not validly) cast.

(3) Shares represented at the AGM for each proposal as a percentage of Coca-Cola HBC's outstanding voting rights, whether exercisable or not. As at the date of the AGM, Coca-Cola HBC's issued share capital consisted of 367,747,133 ordinary shares, of which 14,925 ordinary shares are held by Coca-Cola HBC AG and 3,430,135 shares are held by its subsidiary, Coca-Cola Hellenic Bottling Company S.A., in treasury. Accordingly, the total number of outstanding voting rights in Coca-Cola HBC, whether exercisable or not, was 364,302,073.

 

 

 

 

Enquiries

Coca‑Cola HBC Group

Basak Kotler

Investor Relations Director

 

Tel: +41 41 726 0143

 basak.kotler@cchellenic.com

 

Eri Tziveli

Investor Relations Manager

Tel: +30 210 618 3133

 eri.tziveli@cchellenic.com

 

Dimitris Bakas

Investor Relations Manager

Tel: +30 210 618 3124

 dimitris.bakas@cchellenic.com

 

International media contact:

StockWell Communications

Rob Morgan

Suzanne Bartch

Anushka Mathew

Tel: +44 20 7240 2486

 robert.morgan@stockwellgroup.com

 suzanne.bartch@stockwellgroup.com

 anushka.mathew@stockwellgroup.com

 

Greek media contact:

V+O Communications

Argyro Oikonomou

Tel: +30 211 7501219

 ao@vando.gr

 

About Coca‑Cola HBC

Coca-Cola HBC is the second-largest bottler of the brands of The Coca-Cola Company in terms of volume with sales of more than 2 billion unit cases. It has a broad geographic footprint with operations in 28 countries serving a population of approximately 585 million people. Coca-Cola HBC offers a diverse range of non-alcoholic ready to drink beverages in the sparkling, juice, water, sport, energy, tea and coffee categories. Coca-Cola HBC is committed to promoting sustainable development in order to create value for its business and for society. This includes providing products that meet the beverage needs of consumers, fostering an open and inclusive work environment, conducting its business in ways that protect and preserve the environment and contribute to the socio-economic development of the local communities.

 

Coca-Cola HBC has a premium listing on the London Stock Exchange (LSE: CCH) and its shares are listed on the Athens Exchange (ATHEX: EEE). Coca-Cola HBC's American depositary shares (ADSs) are listed on the New York Stock Exchange (NYSE: CCH). Coca-Cola HBC is included in the Dow Jones Sustainability and FTSE4Good Indexes. For more information, please visit http://www.coca-colahellenic.com.

 

This information is provided by RNS
The company news service from the London Stock Exchange
 
END
 
 
RAGEAPKKALALEEF
Date   Source Headline
18th Jan 202112:26 pmRNSNotice of Results
7th Jan 202110:29 amRNSAthens Exchange trading date of ordinary shares
18th Dec 20201:56 pmRNSDirector/PDMR Shareholding
1st Dec 202011:21 amRNSIssue of equity and total voting rights
19th Nov 20203:44 pmRNSPublication of Suppl.Prospcts
18th Nov 20202:23 pmRNSDirector/PDMR Shareholding
11th Nov 20207:00 amRNSSTRONGLY IMPROVED TRADING IN Q3
2nd Nov 20209:07 amRNSIssue of equity and total voting rights
21st Oct 20205:00 pmRNSAppointment of Chief Financial Officer
19th Oct 20202:26 pmRNSDirector/PDMR Shareholding
12th Oct 202012:44 pmRNSNotice of Results
25th Sep 202010:09 amRNSDirector Declaration
18th Sep 20201:31 pmRNSDirector/PDMR Shareholding
9th Sep 20204:24 pmRNSPublication of Suppl.Prospcts
1st Sep 202010:31 amRNSIssue of equity and total voting rights
18th Aug 202012:28 pmRNSDirector/PDMR Shareholding
13th Aug 20205:08 pmRNSDirector Declaration
7th Aug 202010:54 amRNSDirector/PDMR Shareholding
5th Aug 20207:00 amRNSENCOURAGING SIGNS AS MARKETS REOPEN
4th Aug 20203:05 pmRNSDirector/PDMR Shareholding
3rd Aug 20209:01 amRNSTotal Voting Rights
31st Jul 20202:46 pmRNSNotice of Results-New time for the analysts call
20th Jul 20203:19 pmRNSDirector/PDMR Shareholding
9th Jul 20203:03 pmRNSNotice of Results
7th Jul 20204:45 pmRNSCCH names Naya Kalogeraki Chief Operating Officer
1st Jul 202010:09 amRNSTotal Voting Rights
30th Jun 202011:21 amRNSDirector/PDMR Shareholding
25th Jun 20203:38 pmRNSDirector/PDMR Shareholding
18th Jun 20202:35 pmRNSDirector/PDMR Shareholding
18th Jun 20207:42 amRNSCFO to step down in the first quarter of 2021
16th Jun 20203:54 pmRNSDirector/PDMR Shareholding
16th Jun 20201:42 pmRNSComposition of the Committees of the BoD
16th Jun 20201:06 pmRNSResult of AGM
12th Jun 20201:59 pmRNSAthens Exchange trading date of ordinary shares
9th Jun 20209:40 amRNSDirector/PDMR Shareholding
19th May 20201:08 pmRNSDirector/PDMR Shareholding
14th May 20207:00 amRNSAGM notice, changes to the BoD and dividend dates
11th May 20205:39 pmRNSPublication of Suppl.Prospcts
7th May 20207:00 amRNSKEEPING OUR PEOPLE SAFE AND CUSTOMERS SERVED
1st May 202010:36 amRNSBlock listing Interim Review
30th Apr 20204:13 pmRNSDirector/PDMR Shareholding
30th Apr 20203:59 pmRNSPublication of a Prospectus
27th Apr 20205:42 pmRNSDisclosure of Rights attached to Equity Shares
21st Apr 20201:00 pmRNSDirector/PDMR Shareholding
14th Apr 20203:33 pmRNSNotice of Results
9th Apr 20205:45 pmRNSTotal Voting Rights - Replacement
9th Apr 20205:18 pmRNSTotal Voting Rights
27th Mar 20201:10 pmRNSDirector/PDMR Shareholding
27th Mar 20207:00 amRNSCovid-19 update and actions
19th Mar 20203:39 pmRNSDirector/PDMR Shareholding

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.